{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:44:20Z","timestamp":1773294260187,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00120-026-02771-1","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:27:24Z","timestamp":1770197244000},"page":"242-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Innovatives Imaging f\u00fcr das Urothelkarzinom","Innovative imaging techniques for urothelial carcinoma"],"prefix":"10.1007","volume":"65","author":[{"given":"Jakob","family":"Kohler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severin","family":"Rodler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"J\u00fcptner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"L\u00fctzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Both","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Nuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"2771_CR1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","volume":"87","author":"AG van der Heijden","year":"2025","unstructured":"van der Heijden\u00a0AG, Bruins\u00a0HM, Carrion\u00a0A, et\u00a0al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines. European urology. 2025;87:582\u2013600.","journal-title":"European urology"},{"key":"2771_CR2","unstructured":"Leitlinienprogramm Onkologie. S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms."},{"key":"2771_CR3","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230149","volume":"44","author":"J F\u00e1vero Prietto Dos Santos","year":"2024","unstructured":"F\u00e1vero Prietto Dos Santos\u00a0J, Ghezzi\u00a0CLA, Pedrollo\u00a0IM, et\u00a0al. Practical Guide to VI-RADS: MRI Protocols, Lesion Characterization, and Pitfalls. Radiographics : a review publication of the Radiological Society of North America, Inc. 2024;44:e230149.","journal-title":"Radiographics : a review publication of the Radiological Society of North America, Inc"},{"key":"2771_CR4","doi-asserted-by":"crossref","unstructured":"Beer M, Hechler V, Schmidt S, Bolenz C. VI-RADS - reif f\u00fcr die Praxis? mpMRT bei Blasentumoren. Im Fokus Onkologie; 2021","DOI":"10.1007\/s15015-021-3488-1"},{"key":"2771_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00261-021-03383-3","volume":"47","author":"S Aslan","year":"2022","unstructured":"Aslan\u00a0S, Cakir\u00a0IM, Oguz\u00a0U, et\u00a0al. Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion? Abdom Radiol. 2022;47:771\u201380.","journal-title":"Abdom Radiol"},{"key":"2771_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.euf.2023.08.004","volume":"10","author":"Y Arita","year":"2024","unstructured":"Arita\u00a0Y, Kwee\u00a0TC, Woo\u00a0S, et\u00a0al. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System. European Urology Focus. 2024;10:131\u20138.","journal-title":"European Urology Focus"},{"key":"2771_CR7","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1007\/s00261-025-04852-9","volume":"50","author":"S Aslan","year":"2025","unstructured":"Aslan\u00a0S, Tasdemir\u00a0MN, Cakir\u00a0E, et\u00a0al. Predicting variant histology in bladder cancer: the role of multiparametric MRI and vesical imaging-reporting and data system (VI-RADS). Abdominal radiology (New York). 2025;50:4700\u201311.","journal-title":"Abdominal radiology (New York)"},{"key":"2771_CR8","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/s00330-024-11094-8","volume":"35","author":"R Ebner","year":"2025","unstructured":"Ebner\u00a0R, Sheikh\u00a0GT, Brendel\u00a0M, et\u00a0al. ESR Essentials: staging and restaging with FDG-PET\/CT in oncology-practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging. European radiology. 2025;35:1894\u2013902.","journal-title":"European radiology"},{"key":"2771_CR9","doi-asserted-by":"crossref","unstructured":"Bacchiani M, Salamone V, Massaro E et\u00a0al. Assessing the Performance of 18F-FDG PET\/CT in Bladder Cancer: A\u00a0Narrative Review of Current Evidence. Cancers 2023; 15","DOI":"10.3390\/cancers15112951"},{"key":"2771_CR10","doi-asserted-by":"publisher","first-page":"S464","DOI":"10.1016\/j.jacr.2024.08.022","volume":"21","author":"SJ Barker","year":"2024","unstructured":"Barker\u00a0SJ, Soylu\u00a0E, Allen\u00a0BC, et\u00a0al. ACR Appropriateness Criteria\u00ae Pretreatment Staging of Urothelial Cancer: 2024 Update. Journal of the American College of Radiology : JACR. 2024;21:S464\u2013S89.","journal-title":"Journal of the American College of Radiology : JACR"},{"key":"2771_CR11","doi-asserted-by":"crossref","unstructured":"McDonald S, Keane KG, Gauci R et\u00a0al. Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions. Cancers 2025; 17","DOI":"10.3390\/cancers17020232"},{"key":"2771_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/bju.16091","volume":"132","author":"A Richters","year":"2023","unstructured":"Richters\u00a0A, van Ginkel\u00a0N, Meijer\u00a0RP, et\u00a0al. Staging fluorodeoxyglucose positron emission tomography\/computed tomography for muscle-invasive bladder cancer: a nationwide population-based study. BJU international. 2023;132:420\u20137.","journal-title":"BJU international"},{"key":"2771_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2021.01.005","volume":"5","author":"CS Voskuilen","year":"2022","unstructured":"Voskuilen\u00a0CS, van Gennep\u00a0EJ, Einerhand\u00a0SMH, et\u00a0al. Staging 18F-fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer. European urology oncology. 2022;5:366\u20139.","journal-title":"European urology oncology"},{"key":"2771_CR14","doi-asserted-by":"publisher","first-page":"235.e15","DOI":"10.1016\/j.urolonc.2020.09.035","volume":"39","author":"L Marandino","year":"2021","unstructured":"Marandino\u00a0L, Capozza\u00a0A, Bandini\u00a0M, et\u00a0al. 18FFluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab. Urologic oncology. 2021;39:235.e15\u2013235.e21.","journal-title":"Urologic oncology"},{"key":"2771_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","volume":"77","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice\u00a0F, Barchetti\u00a0G, de Berardinis\u00a0E, et\u00a0al. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. European urology. 2020;77:101\u20139.","journal-title":"European urology"},{"key":"2771_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","volume":"3","author":"S Woo","year":"2020","unstructured":"Woo\u00a0S, Panebianco\u00a0V, Narumi\u00a0Y, et\u00a0al. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. European urology oncology. 2020;3:306\u201315.","journal-title":"European urology oncology"},{"key":"2771_CR17","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1007\/s00330-020-06802-z","volume":"30","author":"C Luo","year":"2020","unstructured":"Luo\u00a0C, Huang\u00a0B, Wu\u00a0Y, et\u00a0al. Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis. European radiology. 2020;30:4606\u201314.","journal-title":"European radiology"},{"key":"2771_CR18","doi-asserted-by":"publisher","first-page":"787.e17","DOI":"10.1016\/j.urolonc.2021.04.024","volume":"39","author":"AC Civelek","year":"2021","unstructured":"Civelek\u00a0AC, Niglio\u00a0SA, Malayeri\u00a0AA, et\u00a0al. Clinical value of 18FDG PET\/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer. Urologic oncology. 2021;39:787.e17\u2013787.e21.","journal-title":"Urologic oncology"},{"key":"2771_CR19","unstructured":"UroToday. ESMO 2025: A New Era in the Treatment of Muscle-Invasive Bladder Cancer \u2013 Discussant of LBA2: Perioperative Enfortumab Vedotin plus Pembrolizumab in Participants with Muscle-Invasive Bladder Cancer Who Are Cisplatin-Ineligible (KEYNOTE-905 study). 2025. Zugegriffen: 2. Nov. 2025."},{"key":"2771_CR20","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1158\/1078-0432.CCR-23-0609","volume":"29","author":"X Duan","year":"2023","unstructured":"Duan\u00a0X, Xia\u00a0L, Zhang\u00a0Z, et\u00a0al. First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin\u20114 for PET\/CT Imaging of Advanced Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023;29:3395\u2013407.","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"2771_CR21","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2967\/jnumed.125.270132","volume":"66","author":"W Huang","year":"2025","unstructured":"Huang\u00a0W, Li\u00a0L, Chao\u00a0F, et\u00a0al. 64CuCu-NOTA-EV-F(ab\u2032)2 Enables Same-Day Immuno-PET Imaging of Nectin\u20114 in Triple-Negative Breast and Urothelial Bladder Cancers. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2025;66:1365\u201371.","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"2771_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/bju.16901","volume":"137","author":"M Miederer","year":"2026","unstructured":"Miederer\u00a0M, Pretze\u00a0M, Abbate\u00a0E, Hartig\u00a0A, do Mar Ferreira Machado\u00a0J, B\u00f6hm\u00a0K, Sommer Uch\u00a0U, Hober\u00fcck\u00a0S, Bundschuh\u00a0RA, et\u00a0al. Staging metastatic urothelial cancer with Nectin\u20114 imaging using Gallium-68-N188 PET\/CT. BJU international. 2026;137:166\u201372.","journal-title":"BJU international"},{"key":"2771_CR23","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2967\/jnumed.124.267474","volume":"65","author":"A Piccardo","year":"2024","unstructured":"Piccardo\u00a0A, Bottoni\u00a0G, Puppo\u00a0C, et\u00a0al. Role of 64CuCl2 PET\/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and 18F-FDG PET\/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2024;65:1357\u201363.","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"2771_CR24","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1007\/s00259-024-06595-z","volume":"51","author":"LM Unterrainer","year":"2024","unstructured":"Unterrainer\u00a0LM, Eismann\u00a0L, Lindner\u00a0S, et\u00a0al. 68 GaGa-FAPI-46 PET\/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis. European journal of nuclear medicine and molecular imaging. 2024;51:1786\u20139.","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"2771_CR25","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1007\/s00259-022-05761-5","volume":"49","author":"LM Unterrainer","year":"2022","unstructured":"Unterrainer\u00a0LM, Lindner\u00a0S, Eismann\u00a0L, et\u00a0al. Feasibility of 68GaGa-FAPI-46 PET\/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma. European journal of nuclear medicine and molecular imaging. 2022;49:3571\u201380.","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"2771_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-025-01727-9","volume":"25","author":"J Marcon","year":"2025","unstructured":"Marcon\u00a0J, Weinhold\u00a0P, Rzany\u00a0M, et\u00a0al. Radiomics-based differentiation of upper urinary tract urothelial and renal cell carcinoma in preoperative computed tomography datasets. BMC medical imaging. 2025;25:196.","journal-title":"BMC medical imaging"},{"key":"2771_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-023-01569-5","volume":"15","author":"R Sun","year":"2024","unstructured":"Sun\u00a0R, Zhang\u00a0M, Yang\u00a0L, et\u00a0al. Preoperative CT-based deep learning radiomics model to predict lymph node metastasis and patient prognosis in bladder cancer: a two-center study. Insights into imaging. 2024;15:21.","journal-title":"Insights into imaging"},{"key":"2771_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12916-025-04163-2","volume":"23","author":"Y Wang","year":"2025","unstructured":"Wang\u00a0Y, Wang\u00a0H, Li\u00a0N, et\u00a0al. Unsupervised learning-based quantitative analysis of CT intratumoral subregions predicts risk stratification of bladder cancer patients. BMC medicine. 2025;23:328\u2013328.","journal-title":"BMC medicine"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02771-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02771-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02771-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:50:34Z","timestamp":1773233434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-026-02771-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2771"],"URL":"https:\/\/doi.org\/10.1007\/s00120-026-02771-1","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Kohler, S.\u00a0Rodler, J.\u00a0Andersson, M.\u00a0J\u00fcptner, U.\u00a0L\u00fctzen, M.\u00a0Both und P.\u00a0Nuhn geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}